Also on Trial Friend:Gastrointestinal Stromal Tumor pageMatch Me
All 47 Gastrointestinal Stromal Tumor trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Integrated Cancer Repository for Cancer ResearchMost sites in Missouri, Nebraska and FloridaRecruitingAges 19-110University of Nebraska42US sites
18 states - A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Most sites in California, Texas and ColoradoRecruitingPhase 1Ages 18+Kura Oncology32US sites
21 states - DESTINY-PANTUMOUR04Most sites in Florida, Arizona and North CarolinaRecruitingAges 18-130AstraZeneca18US sites
13 states - KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)Most sites in Florida, California and IllinoisRecruitingPhase 2Ages 18+Kumquat Biosciences17US sites
15 states - Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Most sites in Illinois, Maryland and CaliforniaRecruitingPhase 2Ages 12+Merck Sharp & Dohme10US sites
8 states - A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Most sites in Florida, California and ColoradoRecruitingPhase 1/2Ages 18+Deciphera Pharmaceuticals9US sites
8 states - (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsMost sites in Florida, District of Columbia and IllinoisRecruitingPhase 3Ages 18+Cogent Biosciences8US sites
6 states - A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitMost sites in Michigan, Ohio and OregonRecruitingPhase 1Ages 18+Novelty Nobility4US sites
4 states - Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaOnly in CaliforniaRecruitingAges 18+Stanford University1US site
- ctDNA-Guided Sunitinib And Regorafenib Therapy for GISTOnly in FloridaRecruitingPhase 2Ages 18+University of Miami1US site
- Imatinib TDM in GISTOnly in KentuckyRecruitingPhase 2Ages 18+Reema A. Patel1US site
- LRG GIST Patient RegistryOnly in New JerseyRecruitingThe Life Raft Group1US site
- PH 2 Pemigatinib in SDH-deficient GISTOnly in MassachusettsRecruitingPhase 2Ages 18+Dana-Farber Cancer Institute1US site
- Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal TumorOnly in CaliforniaRecruitingPhase 1Ages 18+University of California, San Diego1US site
- Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic AnalysisOnly in MarylandRecruitingAges 6+National Cancer Institute (NCI)1US site
- 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High RiskRecruitingPhase 2Ages 20+Asan Medical CenterNo US site yet
- A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal TumorsRecruitingAges 18-75Fujian Medical UniversityNo US site yet
- A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal TumorsRecruitingAges 18+Xinhua Zhang, MDNo US site yet
- A Novel Two-Tooth Clip for ESD and EFTR of GISTRecruitingAges 18-85Affiliated Hospital to Academy of Military Medical SciencesNo US site yet
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingPhase 1/2Ages 18+Cancer Research UKNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Gastrointestinal Stromal Tumor trials in the US, and what stage they are in
Of the 16 Gastrointestinal Stromal Tumor trials with a US site, 1 is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 10 of them. The remaining 5 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 7 of them, and universities, hospitals, foundations and government groups run 9. The most recently listed one first appeared on ClinicalTrials.gov on July 13, 2026.
Gastrointestinal Stromal Tumor trials in the US, state by state
Of the 16 Gastrointestinal Stromal Tumor trials with a US site, 3 accept children under 18. Their open sites are in 9 states, most often Maryland, California and Illinois. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 22 states
US hospitals running the most Gastrointestinal Stromal Tumor trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Gastrointestinal Stromal Tumor.
- Oregon Health & Science UniversityPortland, Oregon3 trials
- Dana Farber Cancer InstituteBoston, Massachusetts2 trials
- Memorial Sloan Kettering Cancer CenterNew York, New York2 trials
- Moffitt Cancer CenterTampa, Florida2 trials
- Northwestern UniversityChicago, Illinois2 trials
- University of California, San DiegoLa Jolla, California2 trials
- University of MiamiMiami, Florida2 trials
- University of Miami - Sylvester Comprehensive Cancer CenterMiami, Florida2 trials
- University of Michigan HospitalsAnn Arbor, Michigan2 trials
- Advent HealthGreenwood Village, Colorado1 trial
Help getting to a Gastrointestinal Stromal Tumor trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Corporate Angel Network
- Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
- American Cancer Society Hope Lodge
- Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Gastrointestinal Stromal Tumor trial near you
Are there Gastrointestinal Stromal Tumor clinical trials near me?
As of November 13, 2026, 47 Gastrointestinal Stromal Tumor clinical trials are recruiting now and 7 are not yet recruiting. In the US, 16 of them have at least 1 open site, across 31 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Gastrointestinal Stromal Tumor clinical trial sites?
Recruiting Gastrointestinal Stromal Tumor trials list open sites in 31 states and Washington, DC. California, Florida and Illinois have the most, and the table on this page lists every state.
Are there Gastrointestinal Stromal Tumor trials for children near me?
Of the 16 Gastrointestinal Stromal Tumor trials with a US site, 3 accept children under 18. Their open sites are in 9 states, most often Maryland, California and Illinois. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Gastrointestinal Stromal Tumor clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.
What if there is no Gastrointestinal Stromal Tumor trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Gastrointestinal Stromal Tumor trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Gastrointestinal Stromal Tumor: Ayvakit (avapritinib), Gleevec (imatinib mesylate), Qinlock (ripretinib), Stivarga (regorafenib), Sutent (sunitinib malate).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.